Lim, Z. C., Hoo, G. S., Ang, J. H., Teng, C. B., Ang, L. W., Lee, C. C., . . . MEDICINE. (2022). Safety and effectiveness of switching to Abacavir/Lamivudine plus rilpivirine for maintenance therapy in virologically suppressed HIV-1 individuals in Singapore (SEALS). BioMed Central Ltd.
Chicago Style CitationLim, Z. C., et al. Safety and Effectiveness of Switching to Abacavir/Lamivudine Plus Rilpivirine for Maintenance Therapy in Virologically Suppressed HIV-1 Individuals in Singapore (SEALS). BioMed Central Ltd, 2022.
MLA CitationLim, Z. C., et al. Safety and Effectiveness of Switching to Abacavir/Lamivudine Plus Rilpivirine for Maintenance Therapy in Virologically Suppressed HIV-1 Individuals in Singapore (SEALS). BioMed Central Ltd, 2022.